Growth Metrics

Innoviva (INVA) Cash from Financing Activities (2010 - 2026)

Innoviva posted quarterly Cash from Financing Activities of -$20.1 million for Q1 2026, down 11108.74% year-on-year from N/an in Q1 2025, and down 264.16% on a QoQ basis from $12.3 million in Q3 2025.

Innoviva (INVA) has 17 years of Cash from Financing Activities data on file, last reported at -$20.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Financing Activities fell 11108.74% year-over-year to -$20.1 million; the trailing twelve-month figure through Mar 2026 stood at -$6.4 million (up 77.05% YoY), and the FY2025 full-year result was $8.6 million, up 163.56% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at -$20.1 million, down from $12.3 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $60.3 million in Q1 2022 and bottomed at -$157.2 million in Q3 2023.
  • The 5-year median for Cash from Financing Activities is -$9.2 million (2023), against an average of -$25.6 million.
  • The widest annual swing landed in 2022, when Cash from Financing Activities soared 383.11%; it then slumped 11108.74% in 2026.
  • A 5-year view of Cash from Financing Activities shows it stood at -$45.6 million in 2022, then slumped by 245.1% to -$157.2 million in 2023, then soared by 91.08% to -$14.0 million in 2024, then surged by 187.49% to $12.3 million in 2025, then sank by 264.16% to -$20.1 million in 2026.
  • The last three Cash from Financing Activities figures came in at -$20.1 million (Q1 2026), $12.3 million (Q3 2025), and $1.2 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 7.00 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -600,000.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 53,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -538.80 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -802.20 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 15.71 Mn
10 Innoviva 1.60 Bn 992.84 Mn 75.83 Mn -20.15 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -20.15 Mn
Mar 31, 2026 -20.15 Mn
Sep 30, 2025 12.27 Mn
Sep 30, 2025 12.27 Mn
Jun 30, 2025 1.25 Mn
Jun 30, 2025 1.25 Mn
Mar 31, 2025 183,000.00
Mar 31, 2025 183,000.00
Sep 30, 2024 -14.03 Mn
Sep 30, 2024 -14.03 Mn
Jun 30, 2024 -5.07 Mn
Jun 30, 2024 -5.07 Mn
Mar 31, 2024 -9.17 Mn
Mar 31, 2024 -9.17 Mn
Sep 30, 2023 -157.25 Mn
Sep 30, 2023 -157.25 Mn
Jun 30, 2023 -9.21 Mn
Jun 30, 2023 -9.21 Mn
Mar 31, 2023 -136.96 Mn
Mar 31, 2023 -136.96 Mn
Sep 30, 2022 -45.57 Mn
Sep 30, 2022 -45.57 Mn
Jun 30, 2022 -9.74 Mn
Jun 30, 2022 -9.74 Mn
Mar 31, 2022 60.33 Mn
Mar 31, 2022 60.33 Mn
Sep 30, 2021 -440.43 Mn
Sep 30, 2021 -440.43 Mn
Jun 30, 2021 -414.26 Mn
Jun 30, 2021 -414.26 Mn
Mar 31, 2021 -21.31 Mn
Mar 31, 2021 -21.31 Mn
Dec 31, 2020 -2.51 Mn
Dec 31, 2020 -2.51 Mn
Sep 30, 2020 -12,000.00
Sep 30, 2020 -12,000.00
Jun 30, 2020 -11.63 Mn
Jun 30, 2020 -11.63 Mn
Mar 31, 2020 -15.64 Mn
Mar 31, 2020 -15.64 Mn
Dec 31, 2019 -13.75 Mn
Dec 31, 2019 -13.75 Mn
Sep 30, 2019 -10.47 Mn
Sep 30, 2019 -10.47 Mn
Jun 30, 2019 198,000.00
Jun 30, 2019 198,000.00
Mar 31, 2019 246,000.00
Mar 31, 2019 246,000.00
Dec 31, 2018 -2.38 Mn
Dec 31, 2018 -2.38 Mn
Sep 30, 2018 -112.25 Mn
Sep 30, 2018 -112.25 Mn
Jun 30, 2018 -715,000.00
Jun 30, 2018 -715,000.00
Mar 31, 2018 -122.63 Mn
Mar 31, 2018 -122.63 Mn
Dec 31, 2017 -87.06 Mn
Dec 31, 2017 -87.06 Mn
Sep 30, 2017 -10.93 Mn
Sep 30, 2017 -10.93 Mn
Jun 30, 2017 -56.84 Mn
Jun 30, 2017 -56.84 Mn
Mar 31, 2017 -8.36 Mn
Mar 31, 2017 -8.36 Mn
Dec 31, 2016 -19.58 Mn
Dec 31, 2016 -19.58 Mn
Sep 30, 2016 -24.84 Mn
Sep 30, 2016 -24.84 Mn
Jun 30, 2016 -26.80 Mn
Jun 30, 2016 -26.80 Mn
Mar 31, 2016 -26.35 Mn
Mar 31, 2016 -26.35 Mn
Dec 31, 2015 -25.77 Mn
Dec 31, 2015 -25.77 Mn
Sep 30, 2015 -25.61 Mn
Sep 30, 2015 -25.61 Mn
Jun 30, 2015 -27.83 Mn
Jun 30, 2015 -27.83 Mn
Mar 31, 2015 -27.71 Mn
Mar 31, 2015 -27.71 Mn
Dec 31, 2014 -9.75 Mn
Dec 31, 2014 -9.75 Mn
Sep 30, 2014 -7.86 Mn
Sep 30, 2014 -7.86 Mn
Jun 30, 2014 148.42 Mn
Jun 30, 2014 148.42 Mn
Mar 31, 2014 18.27 Mn
Mar 31, 2014 18.27 Mn
Dec 31, 2013 13.02 Mn
Dec 31, 2013 13.02 Mn
Sep 30, 2013 113.57 Mn
Sep 30, 2013 113.57 Mn
Jun 30, 2013 23.39 Mn
Jun 30, 2013 23.39 Mn
Mar 31, 2013 247.86 Mn
Mar 31, 2013 247.86 Mn
Dec 31, 2012 6.72 Mn
Dec 31, 2012 6.72 Mn
Sep 30, 2012 12.42 Mn
Sep 30, 2012 12.42 Mn
Jun 30, 2012 214.26 Mn
Jun 30, 2012 214.26 Mn
Mar 31, 2012 2.48 Mn
Mar 31, 2012 2.48 Mn
Dec 31, 2011 2.85 Mn
Dec 31, 2011 2.85 Mn
Sep 30, 2011 1.31 Mn
Sep 30, 2011 1.31 Mn
Jun 30, 2011 9.77 Mn
Jun 30, 2011 9.77 Mn
Mar 31, 2011 11.67 Mn
Mar 31, 2011 11.67 Mn
Dec 31, 2010 133.34 Mn
Dec 31, 2010 133.34 Mn
Sep 30, 2010 1.38 Mn
Sep 30, 2010 1.38 Mn